Andrew Bird
Overview
Explore the profile of Andrew Bird including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
719
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bird A, Wilson K, Bertinara A, Amos L
Br J Nurs
. 2019 Mar;
28(5):S4-S5.
PMID: 30907640
No abstract available.
12.
Wilby D, Riches S, Daly I, Bird A, Wheelwright M, J Foster J
J Exp Biol
. 2018 Jul;
221(Pt 13).
PMID: 29976733
Animals can make use of camouflage to reduce the likelihood of visual detection or recognition and thus improve their chances of survival. Background matching, where body colouration is closely matched...
13.
Bird A
Br J Nurs
. 2017 Dec;
26(22):S14-S16.
PMID: 29240473
Andrew Bird, Lead Stoma Care Nurse Specialist, Colorectal and Stoma Care, Surgery Division, Queen's Medical Centre Campus, Nottingham University Hospitals NHS Trust, Andrew.Bird@nuh.nhs.uk.
14.
Powis R, Bird A, Brennan M, Hinks S, Newman H, Reed K, et al.
Radiat Oncol
. 2017 May;
12(1):81.
PMID: 28482845
Background: A knowledge based planning tool has been developed and implemented for prostate VMAT radiotherapy plans providing a target average rectum dose value based on previously achievable values for similar...
15.
Application of an Integrated Blowout Model System, OILMAP DEEP, to the Deepwater Horizon (DWH) Spill
Spaulding M, Li Z, Mendelsohn D, Crowley D, French-McCay D, Bird A
Mar Pollut Bull
. 2017 May;
120(1-2):37-50.
PMID: 28476353
OILMAP DEEP, an integrated system of models (pipeline release, blowout plume, dispersant treatment, oil droplet size distribution, and fountain and intrusion), was applied to the Deepwater Horizon (DWH) oil spill...
16.
Landau D, Brooks E, Perez-Pinera P, Amarasekara H, Mefferd A, Li S, et al.
Mol Ther
. 2016 Feb;
24(4):697-706.
PMID: 26865405
Glycogen storage disease type Ia (GSD Ia) is caused by glucose-6-phosphatase (G6Pase) deficiency in association with severe, life-threatening hypoglycemia that necessitates lifelong dietary therapy. Here we show that use of...
17.
Han S, Li S, Bird A, Koeberl D
Hum Gene Ther
. 2015 Sep;
26(11):743-50.
PMID: 26417913
Pompe disease (glycogen storage disease type II; acid maltase deficiency) is a devastating myopathy resulting from acid α-glucosidase (GAA) deficiency in striated and smooth muscle. Despite the availability of enzyme...
18.
Han S, Li S, Brooks E, Masat E, Leborgne C, Banugaria S, et al.
Hum Gene Ther
. 2014 Nov;
26(1):26-35.
PMID: 25382056
Enzyme replacement therapy (ERT) is the standard-of-care treatment of Pompe disease, a lysosomal storage disorder caused by deficiency of acid α-glucosidase (GAA). One limitation of ERT with recombinant human (rh)...
19.
Farah B, Madden L, Li S, Nance S, Bird A, Bursac N, et al.
FASEB J
. 2014 Jan;
28(5):2272-80.
PMID: 24448824
Enzyme or gene replacement therapy with acid α-glucosidase (GAA) has achieved only partial efficacy in Pompe disease. We evaluated the effect of adjunctive clenbuterol treatment on cation-independent mannose-6-phosphate receptor (CI-MPR)-mediated...
20.
Zhang P, Luo X, Bird A, Li S, Koeberl D
Biores Open Access
. 2013 Mar;
1(3):109-14.
PMID: 23514839
We have previously shown that antibody and T cell responses limit the efficacy of an adeno-associated virus (AAV) pseudotype 8 (2/8) vector containing the universally active cytomegalovirus enhancer/chicken β-actin regulatory...